The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea ...

Rising Incidence of Chronic Respiratory Diseases Drives Market DemandThe Respiratory Care Devices Market has emerged as a ...

Using different oximeter devices for monitoring stable patients under NIV or CPAP may have an unpredictable effect on results and clinical decisions.

AI-enabled and non-invasive ventilators enhance ICU efficiency and patient care, driving the global mechanical ventilators ...

Significant market opportunities in the Europe at-home respiratory care services sector include growing demand driven by technological advancements like smart inhalers, increased prevalence of chronic ...

Masks rather than nasal prongs may reduce the risk of continuous positive airway pressure (CPAP) treatment failure and nasal injury but may have little or no impact on the risk of death or other ...

Philips Respironics, Inc. has issued updated instructions for the use of its OmniLab Advanced+ (OLA+) Ventilator because of its demonstrated failure in the ventilator inoperative alarm that can cause ...

Philips agrees to pay $1.1 billion to settle U.S. litigation over recalled sleep apnea devices. Turkey in talks with Exxon over a multibillion-dollar deal to buy liquefied natural gas. Skydance Media ...

A Philips Respironics System One unit, used to treat sleep apnea, in 2015. (Jasper Juinen/Bloomberg News) The stock rose some 29% in Amsterdam, its largest increase on record. The data goes back to ...

In hospitalized veterans with COVID-19, obstructive sleep apnea (OSA) was associated with greater use of non-invasive ventilation (NIV), but booster vaccination reduced this risk, a retrospective ...